Sigma Planning Corp Provention Bio, Inc. Transaction History

Sigma Planning Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$6.7 - $24.21 $410,643 - $1.48 Million	-61,290 Reduced 39.85%	92,500 $2.23 Million
Q4 2022 Jan 24, 2023	BUY	$4.52 - $10.57 $451 - $1,057	100 Added 0.07%	153,790 $0
Q2 2022 Aug 11, 2022	BUY	$3.65 - $7.3 $102,455 - $204,911	28,070 Added 22.35%	153,690 $615,000
Q1 2022 Apr 20, 2022	BUY	$3.4 - $7.88 $12,325 - $28,565	3,625 Added 2.97%	125,620 $920,000
Q4 2021 Feb 02, 2022	BUY	$5.59 - $7.39 $9,223 - $12,193	1,650 Added 1.37%	121,995 $686,000
Q3 2021 Oct 28, 2021	BUY	$5.66 - $8.33 $55,920 - $82,300	9,880 Added 8.94%	120,345 $770,000
Q2 2021 Aug 13, 2021	BUY	$6.71 - $11.04 $168,622 - $277,435	25,130 Added 29.45%	110,465 $931,000
Q1 2021 May 06, 2021	BUY	$10.12 - $19.45 $265,599 - $510,465	26,245 Added 44.42%	85,335 $896,000
Q4 2020 Feb 09, 2021	BUY	$11.79 - $18.94 $5,305 - $8,523	450 Added 0.77%	59,090 $1 Million
Q3 2020 Nov 03, 2020	SELL	$10.34 - $15.2 $4,136 - $6,080	-400 Reduced 0.68%	58,640 $752,000
Q2 2020 Jul 31, 2020	SELL	$7.81 - $17.0 $139,330 - $303,280	-17,840 Reduced 23.2%	59,040 $833,000
Q1 2020 May 01, 2020	SELL	$5.42 - $17.75 $18,997 - $62,213	-3,505 Reduced 4.36%	76,880 $707,000
Q4 2019 Feb 03, 2020	BUY	$5.84 - $14.9 $67,072 - $171,126	11,485 Added 16.67%	80,385 $1.2 Million
Q3 2019 Nov 01, 2019	BUY	$6.83 - $13.0 $74,788 - $142,350	10,950 Added 18.9%	68,900 $470,000
Q2 2019 Aug 01, 2019	BUY	$2.3 - $13.79 $133,285 - $799,130	57,950 New	57,950 $701,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.